Automation in the Biopharma Industry Market Outlook Strengthens as Global Demand Increases

The Business Research Company

Biopharma Industry Market

The Business Research Company’s Automation in the Biopharma Industry Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON , UNITED KINGDOM, November 4, 2026 /EINPresswire.com/ -- The automation sector within the biopharma industry is experiencing significant growth, driven by advances in technology and evolving manufacturing needs. As biopharmaceutical production becomes more complex, the industry is increasingly turning to automated solutions to boost efficiency and meet regulatory demands. Let’s explore the current market size, key growth factors, major trends, and regional insights shaping this dynamic market.

Forecast and Market Size Expansion of Automation in the Biopharma Industry
The automation in biopharma industry market has demonstrated strong growth recently and is expected to continue this trajectory. Market value is projected to rise from $2.19 billion in 2025 to $2.35 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.1%. This expansion in the past years has been driven by factors such as the increasing complexity of biologic drug manufacturing, a surge in demand for scalable biopharma production, early integration of laboratory automation, growth in contract manufacturing services, and advances in process control technologies.

Download a free sample of the automation in biopharma industry market report:
https://thebusinessresearchcompany.com/sample_request?id=70009064&type=smp&name=Automation%20In%20Biopharma%20Industry%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

Looking ahead, the market is forecasted to grow even more rapidly, reaching $3.16 billion by 2030 with a CAGR of 7.7%. This expected growth will be fueled by rising investments in smart biomanufacturing plants, wider adoption of continuous manufacturing methods, expansion in personalized biologics production, increasing demand for automation that complies with regulatory standards, and a stronger focus on optimizing manufacturing efficiency. Key trends shaping this future include the growing use of robotic manufacturing systems, integration of digital twin technology, deployment of automated quality control solutions, comprehensive bioprocess automation, and a data-driven approach to production management.

Understanding Automation in the Biopharma Industry
Automation in the biopharma sector involves incorporating advanced technologies and robotics into various phases of biopharmaceutical manufacturing. This integration replaces many manual tasks with automated systems and equipment designed to enhance efficiency, improve accuracy, and increase overall productivity in the production of biopharmaceutical products.

View the full automation in biopharma industry market report:
https://thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

Factors Propelling Growth in Automation for Biopharma Manufacturing
A major driver of market growth is the rising use of robots in pharmaceutical manufacturing processes. These advanced automated machines perform diverse functions such as secondary packaging, intralogistics, laboratory automation, pick-and-place operations, pharmacy process automation, and personalized medicine production. The use of robotics not only boosts productivity and precision but also reduces contamination risks and improves worker safety.

Supporting this trend, in September 2024, the International Federation of Robotics, a Germany-based professional non-profit organization, reported a 9% increase in industrial robot installations across Europe’s manufacturing sector, reaching a record total of 92,393 units. Of these, 80%—or 73,534 units—were installed within the European Union, marking a 2% rise from the previous year. This growing adoption of robots in pharmaceutical production is a key factor driving the advancement of automation in the biopharma industry market.

Dominant Regional Player in the Automation in Biopharma Industry Market
North America held the largest share of the automation in biopharma industry market in 2025. The market report takes into account several regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive overview of the global market landscape.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company.

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X